WHO ICTRP trial
Ö-PKU 1 – Evaluation of a Test for the identication of BH4 responsive PKU…
EUCTR2010-019767-11-AT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-019767-11-AT |
|---|---|
| Public title | Ö-PKU 1 – Evaluation of a Test for the identication of BH4 responsive PKU patients - Ö-PKU1 |
| Scientific title | Ö-PKU 1 – Evaluation of a Test for the identication of BH4 responsive PKU patients - Ö-PKU1 |
| Primary sponsor | Graz Medical University |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Austria |
| Conditions | Hyperphenylalaninaemia (HPA) in adult and paediatric patients of 4 years of age and over with phenylketonuria (PKU). |
| Interventions | Trade Name: Kuvan Pharmaceutical Form: Soluble tablet |
| Registration date | Oct 8, 2010 |
| Secondary IDs | Ö-PKU1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: